---
title: "ENTA.US (ENTA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ENTA.US/news.md"
symbol: "ENTA.US"
name: "ENTA.US"
parent: "https://longbridge.com/en/quote/ENTA.US.md"
datetime: "2026-05-20T02:33:27.774Z"
locales:
  - [en](https://longbridge.com/en/quote/ENTA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ENTA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ENTA.US/news.md)
---

# ENTA.US (ENTA.US) — Related News

### [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
*2026-05-19T10:34:03.000Z*
> Enanta Pharmaceuticals Inc. (ENTA) is showcasing its investigational programs, Zelicapavir and EPS-3903, at the ATS Inte

### [ENANTA PHARMACEUTICALS INC 3Q 2026: Revenue $17.16M, EPS $(0.45) — 10-Q Summary](https://longbridge.com/en/news/286249442.md)
*2026-05-13T11:11:00.000Z*
> Enanta Pharmaceuticals Inc reported Q3 2026 revenue of $17.16M, a 15% increase from $14.93M in the previous year. The ne

### [](https://longbridge.com/en/news/286137335.md)
*2026-05-12T16:43:02.000Z*
> Enanta Pharma shares are trading lower. The company reported Q2 financial results.

### [Enanta Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 17.16 M](https://longbridge.com/en/news/285988788.md)
*2026-05-11T20:08:27.000Z*
### [Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026 | ENTA Stock News](https://longbridge.com/en/news/285987900.md)
*2026-05-11T12:01:00.000Z*
> Enanta Pharmaceuticals reported its fiscal second quarter results for the period ending March 31, 2026, with total reven

### [ENTA Q2'26 Earnings: revenue estimate is 17.03M USD](https://longbridge.com/en/news/285060876.md)
*2026-05-04T11:00:27.000Z*
> ENTA (Enanta Pharmaceuticals, Inc.) is set to announce its Q2'26 results on May 11, time not specified. The earnings are